What drugs does GE HLTHCARE INC make?

GE HLTHCARE INC has 2 FDA-approved drugs including FLYRCADO, DATSCAN.

What therapeutic areas does GE HLTHCARE INC focus on?

GE HLTHCARE INC focuses primarily on Neurology.

← Back

Data updated: Mar 29, 2026

GE HLTHCARE INC

Neurology

Pharma

GE HLTHCARE INC is a pharmaceutical company focused on Neurology. Key products include FLYRCADO.

2011

Since

Drugs

Trials

Approved (2yr)

Key Drugs

FLYRCADO

flurpiridaz f-18

Cardiovascular

Mitochondrial complex 1 3 indications · 2024

DATSCAN

ioflupane i-123

DAT 2 indications · 2011

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

FLYRCADO 2024-09-27

Type 1 - New Molecular Entity

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 100%

1 drugs

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

Bristol-Myers Squibb big-pharma

Neurology

GE HLTHCARE INC

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (2)

Active (2)

Discontinued (0)

Company Info

GE HLTHCARE INC

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (2)

Active (2)

Discontinued (0)

Company Info